End Cash: The amount of cash held by the company for the given period.
Vivos Therapeutics, Inc. (VVOS) had End Cash of $3.09M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$6.78M |
|
$-5.40M |
|
$2.85M |
|
$3.94M |
|
$11.52M |
|
$-4.73M |
|
$-0.67M |
|
$-5.40M |
|
$-5.40M |
|
$-5.40M |
|
$-5.40M |
|
$-5.40M |
|
$-5.40M |
|
$-4.73M |
|
$-4.35M |
|
10.96M |
|
10.96M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$5.79M |
|
$5.64M |
|
$19.86M |
|
$25.64M |
|
$7.44M |
|
$8.38M |
|
$15.68M |
|
$23.11M |
|
$2.53M |
|
$-8.09M |
|
$2.53M |
|
8.27M |
|
| Cash Flow Statement Financials | |
$-11.45M |
|
$-5.95M |
|
$14.22M |
|
$6.26M |
|
|
End Cash |
$3.09M |
$-3.17M |
|
$0.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.78 |
|
-- |
|
-- |
|
0.77 |
|
3.44 |
|
58.04% |
|
-69.79% |
|
-69.79% |
|
-- |
|
-79.61% |
|
-79.61% |
|
$-12.26M |
|
-- |
|
-- |
|
-- |
|
0.26 |
|
-- |
|
3.18 |
|
28.31 |
|
-213.27% |
|
66.75% |
|
-21.06% |
|
-49.49% |
|
$0.31 |
|
$-1.12 |
|
$-1.04 |
|